Literature DB >> 3876106

Resistance of human T-CFUcs to activated cyclophosphamide: a feature common with critical marrow stem cells?

J E Byfield, P M Calabro-Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876106      PMCID: PMC1977205          DOI: 10.1038/bjc.1985.208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  Characterization and quantitative estimation of activated cyclophosphamide in blood and urine.

Authors:  T Wagner; G Peter; G Voelcker; H J Hohorst
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

2.  Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.

Authors:  C Fenselau; M N Kan; S S Rao; A Myles; O M Friedman; M Colvin
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens.

Authors:  S P Lerman; W P Weidanz
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

4.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

5.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

6.  Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents.

Authors:  J E Byfield; P M Calabro-Jones
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

7.  Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents.

Authors:  J P Murnane; J E Byfield; J F Ward; P Calabro-Jones
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

8.  Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.

Authors:  S J Sharkis; G W Santos; M Colvin
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

9.  Murine B-lymphocyte colony formation: the effects of cyclophosphamide and azathioprine.

Authors:  A Winkelstein
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

10.  Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.

Authors:  J E Byfield; J Murnane; J F Ward; P Calabro-Jones; M Lynch; F Kulhanian
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

View more
  1 in total

1.  A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide.

Authors:  G Molineux; C Xu; J Hendry; N G Testa
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.